Elsevier

The Lancet

Volume 354, Issue 9184, 25 September 1999, Pages 1091-1092
The Lancet

Research Letters
Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine

https://doi.org/10.1016/S0140-6736(99)03010-XGet rights and content

Summary

After the introduction of a Haemophilus influenzae type b (Hib) conjugate vaccine into The Gambia, the annual incidence of Hib meningitis has fallen from more than 200 per 100 000 before vaccination to 21 per 100 000 during the past 12 months.

Cited by (53)

  • Evaluating the frequency of bacterial co-infections in children recruited into a malaria pathogenesis study in The Gambia, West Africa using molecular methods

    2012, Molecular and Cellular Probes
    Citation Excerpt :

    DGGE-based sequencing was, therefore, a useful technique in ruling out infections with pathogenic bacteria, even in samples containing DNA originating from more than one bacterial species, where the combination of 16S rRNA PCR and direct sequencing often fails to separate mixed bacterial DNA. To provide support that co-infections with pathogenic bacteria were absent from this study group, species-specific primers were used in PCR to search for the most likely causes of co-infection in The Gambia, for example S. pneumoniae [43], which mostly causes pneumonia and which may be misdiagnosed as malaria due to a similar clinical presentation. S. pneumoniae specific qPCR (lytA) was performed on all 55 MS gDNA samples to assess the presence of an S. pneumoniae co-infection.

  • Haemophilus influenzae

    2011, Tropical Infectious Diseases: Principles, Pathogens and Practice
  • Haemophilus Influenzae

    2011, Tropical Infectious Diseases
  • Incidence of childhood Haemophilus influenzae type b meningitis in Sri Lanka

    2010, International Journal of Infectious Diseases
    Citation Excerpt :

    Haemophilus influenzae type b (Hib) is considered to be the most common cause of bacterial meningitis and one of the most common causes of invasive infections among young children worldwide, except in countries where Hib conjugate vaccines have been introduced into the routine immunization program.1,2

View all citing articles on Scopus
View full text